CGD
Epigenetics Symposium
Tuesday 8
August, 9:45am-2:40pm at Seminar Room 2, Level 2, TRF Building.
Background briefing:
Dr Patrick Western will present an overview of
epigenetics that will set the scene for the audience. It will provide
the basic building blocks for members of the Institute who are attending
an epigenetics symposium for the first time and act as a refresher
for those who are keen to improve their knowledge base in this area.
Speakers
Assoc Prof
Jeffrey Craig (Murdoch Childrens Research Institute)
Identification
of epigenetic biomarkers for chronic disease: a twin odyssey
Assoc Prof
Marnie Blewitt (Walter and Eliza Hall Institute of Medical Research)
Using
functional genomics to decipher the mechanistic role of Smchd1 in epigenetic
silencing in normal development and disease.
Dr Rhys Allan (Walter and Eliza Hall
Institute of Medical Research)
Surveying
three-dimensional genome organization during development of the mammalian
immune system
Plus student
presentations throughout the symposium.
Associate Professor Jeffrey Craig
Murdoch Childrens Research Institute
Identification of epigenetic biomarkers for chronic disease: a twin odyssey
Associate Professor Craig leads the Early Life Epigenetics Research Group at the Murdoch Childrens Research Institute and is an Honorary Associate Professor within the Department of Paediatrics, University of Melbourne. He has established a number of longitudinal cohorts including the Peri/postnatal Epigenetic Twin cohort. Dr Craig is a passionate twin researcher and is Deputy Director of the Australian Twin Registry. His work focuses on epigenetic changes associated with early development and the link between environmental factors, development and disease, in particular cardiovascular and neurodevelopmental disorders. He is currently developing epigenetic biomarkers to integrate into disease risk models.
Associate Professor Marnie Blewitt
Walter and Eliza Hall Institute of Medical Research
Using functional genomics to decipher the mechanistic role of Smchd1 in epigenetic silencing in normal development and disease.
Marnie completed her PhD with Emma Whitelaw at The University of Sydney, developing a sensitised mutagenesis screen for novel epigenetic modifiers in the mouse, for which she was awarded the Genetics Society of Australia DG Catcheside prize. Marnie took up a NHMRC fellowship with Doug Hilton at WEHI. She continued to work on Smchd1 that she identified in her PhD, plus studied the role of polycomb group proteins in hematopoietic stem cells. This work earned her the AAS Gani medal and the L’Oreal Australia Women in Science fellowship 2009. In 2010, Marnie established her own group at the Walter and Eliza Hall Institute as an ARC QEII fellow, working on the molecular mechanisms of epigenetic control. She is now a Bellberry-Viertel Senior Medical Research fellow, and a Joint Division head for the Molecular Medicine division at WEHI. Her recent work earned her the Lorne Genome Women in Science Award 2015.
Dr Rhys Allan
Walter and Eliza Hall Institute of Medical Research
Surveying three-dimensional genome organization during development of the mammalian immune system
Rhys Allan is an ARC Future Fellow and laboratory head in the Molecular Immunology Division at the Walter and Eliza Hall Institute. He completed his PhD at the University of Melbourne with Professor Francis Carbone in 2007 and following a post-doctoral period at Institut Curie and the Walter and Eliza Hall Institute he started his own lab in 2015. His work has contributed to understanding the generation of immunity and how epigenetic modifications to chromatin influence cellular stability and lineage commitment. He will present new work from his lab that is taking a genome-wide approach to study the role of chromatin architecture in regulating cell fate and lineage commitment.
No comments:
Post a Comment